SUBSCRIBERS

Qualitas Medical delays SGX IPO, cites non-optimal pricing and market volatility

Published Thu, Apr 26, 2018 · 09:50 PM

DeeperDive is a beta AI feature. Refer to full articles for the facts.

Singapore

QUALITAS Medical is delaying its initial public offering (IPO) on the Singapore Exchange's (SGX) main board because of pricing and market volatility, the regional clinic operator said.

"While our book was well supported, including commitments from anchor investors, we believe pricing was not optimal given, amongst other things, recent market volatility," said Qualitas, which had been expected to launch a deal reported to be worth S$100-133 million.

Copyright SPH Media. All rights reserved.